Introduction to suprax
Suprax is a brand name for cefixime, a third-generation cephalosporin antibiotic that is used to treat various bacterial infections. Cefixime was developed in the 1980s and was approved by the U.S. Food and Drug Administration in 1989. As a third-generation cephalosporin, cefixime has enhanced activity against gram-negative bacteria compared to first- and second-generation cephalosporins, while maintaining reasonable activity against many gram-positive organisms. The drug works by inhibiting bacterial cell wall synthesis, specifically by binding to penicillin-binding proteins (PBPs) and interfering with the transpeptidation step of peptidoglycan cross-linking. This leads to bacterial cell lysis and death. Suprax is available in oral formulations, including tablets and oral suspension, making it convenient for outpatient treatment of various infections. It is commonly used for respiratory tract infections, urinary tract infections, otitis media, and sexually transmitted infections such as gonorrhea. The convenience and efficacy of Suprax have made it a popular choice among clinicians and patients. Those who need this antibiotic can conveniently buy Suprax over the counter at reputable online pharmacies. This comprehensive article provides detailed information about Suprax, covering its chemical properties, mechanism of action, clinical indications, dosing, side effects, drug interactions, and frequently asked questions to help patients make informed decisions about their treatment.
Chemical structure and properties
Cefixime has the chemical formula C16H15N5O7S2 and a molecular weight of 453.45 g/mol. Its chemical structure features a cephalosporin core consisting of a beta-lactam ring fused to a dihydrothiazine ring. The side chain at position 7 contains an aminothiazole group and a carboxymethoxyimino group, which are characteristic of third-generation cephalosporins and contribute to the drug’s enhanced activity against gram-negative bacteria. The carboxylic acid group at position 4 is essential for binding to penicillin-binding proteins. Cefixime appears as a white to pale yellow crystalline powder that is slightly soluble in water and methanol. The drug is stable under acidic conditions, which allows for oral administration. The molecular structure allows cefixime to penetrate the outer membrane of gram-negative bacteria more effectively than earlier cephalosporins, and it is highly resistant to hydrolysis by many beta-lactamases produced by gram-negative organisms. The chemical properties of cefixime contribute to its favorable pharmacokinetic profile, including good oral bioavailability and a relatively long half-life that supports once or twice daily dosing. Understanding the chemical structure of cefixime helps explain its antibacterial spectrum, stability against beta-lactamases, and clinical utility in treating various infections.
Mechanism of action
Suprax (cefixime) exerts its bactericidal effects by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), which are transpeptidase enzymes responsible for cross-linking the peptidoglycan polymer chains that make up the bacterial cell wall. By binding to these PBPs, cefixime inhibits the final transpeptidation step of peptidoglycan synthesis, preventing the formation of a functional cell wall. This leads to weakening of the cell wall structure and, ultimately, osmotic lysis and death of the bacterial cell. As a beta-lactam antibiotic, cefixime requires actively dividing bacteria to exert its effect, as cell wall synthesis occurs during bacterial growth. The selectivity of cefixime for bacterial cells is due to the fact that mammalian cells do not possess cell walls. Cefixime has a broad spectrum of antibacterial activity. It is highly active against many gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Haemophilus influenzae (including beta-lactamase-producing strains), Moraxella catarrhalis, Neisseria gonorrhoeae (including penicillinase-producing strains), and Neisseria meningitidis. It also has activity against some gram-positive bacteria, including Streptococcus pneumoniae, Streptococcus pyogenes, and Streptococcus agalactiae. However, cefixime has limited activity against Staphylococcus aureus and other staphylococci. Its activity against Pseudomonas aeruginosa is minimal. The drug is highly stable against many beta-lactamases, particularly the TEM-type enzymes commonly produced by gram-negative bacteria, which contributes to its effectiveness against organisms that are resistant to earlier cephalosporins. However, it can be hydrolyzed by extended-spectrum beta-lactamases (ESBLs) and AmpC beta-lactamases produced by some gram-negative bacteria. Understanding the mechanism of action and antibacterial spectrum of Suprax is essential for appropriate clinical use and for recognizing its limitations.
Pharmacokinetics
The pharmacokinetic profile of Suprax (cefixime) involves good oral absorption, extensive tissue distribution, and renal elimination. After oral administration, cefixime is approximately 40 to 50% absorbed from the gastrointestinal tract. The presence of food may delay the time to peak concentration but does not affect the extent of absorption. Peak plasma concentrations are achieved within 3 to 4 hours after oral administration. The oral suspension formulation may be absorbed more quickly than the tablet formulation. Once absorbed, cefixime is distributed throughout the body, including into the respiratory tract, urinary tract, middle ear fluid, tonsils, and bile. It achieves concentrations in these tissues that exceed the minimum inhibitory concentrations for many susceptible pathogens. Cefixime penetrates well into bronchial mucosa, sputum, pleural fluid, and middle ear effusions. It does not penetrate the blood-brain barrier well in the absence of inflammation, and concentrations in the cerebrospinal fluid are low. Cefixime is approximately 65 to 70% bound to plasma proteins. The volume of distribution is approximately 0.3 L/kg. Cefixime is not metabolized in the body. Approximately 50% of an absorbed dose is excreted unchanged in the urine through glomerular filtration and tubular secretion. A smaller amount is eliminated in the bile and feces. The elimination half-life of cefixime is approximately 3 to 4 hours in healthy adults, which supports once or twice daily dosing. In patients with renal impairment, the half-life can be prolonged, necessitating dose adjustment. In patients with creatinine clearance between 20 and 40 mL/min, the half-life is approximately 7 hours, and dose reduction is recommended. In patients with creatinine clearance less than 20 mL/min, the half-life can be extended to over 11 hours, and further dose reduction is necessary. Cefixime is not removed by hemodialysis. Understanding the pharmacokinetic properties of Suprax is important for optimizing dosing regimens, particularly in patients with impaired renal function.
Clinical indications and uses
Suprax (cefixime) is indicated for the treatment of various bacterial infections in both adults and children. Its primary clinical applications include upper respiratory tract infections, such as pharyngitis and tonsillitis caused by Streptococcus pyogenes. It is an alternative to penicillin for patients who are allergic to penicillin or for whom penicillin therapy is not appropriate. For acute otitis media in children, cefixime is effective against common pathogens including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. It is particularly useful for beta-lactamase-producing strains of H. Influenzae and M. Catarrhalis that are resistant to amoxicillin. Lower respiratory tract infections, including acute bronchitis and acute exacerbations of chronic bronchitis, are also indications for cefixime therapy. It is effective against Streptococcus pneumoniae, Haemophilus influenzae, and Klebsiella pneumoniae. In the treatment of urinary tract infections, cefixime is indicated for uncomplicated cystitis and pyelonephritis caused by susceptible organisms, including Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis. Its activity against gram-negative pathogens makes it a useful option for complicated urinary tract infections as well. Uncomplicated gonorrhea is a major indication for cefixime. It is recommended as a first-line treatment for uncomplicated urogenital, anorectal, and pharyngeal gonorrhea in many treatment guidelines. A single oral dose of 400 mg is effective for most cases. Cefixime is also indicated for the treatment of typhoid fever (enteric fever) caused by Salmonella typhi, particularly in areas where fluoroquinolone resistance is prevalent. It has been used effectively in the treatment of shigellosis and other gastrointestinal infections. Other indications include the treatment of Lyme disease (early stage), periodontitis, and pelvic inflammatory disease (in combination with other antibiotics). The broad range of indications for Suprax demonstrates its versatility as an antibiotic, and patients can buy Suprax over the counter for many of these common infections.
Dosage and administration
The dosage of Suprax (cefixime) depends on the type and severity of the infection, the age and weight of the patient, and renal function. For adults with normal renal function, the usual dose for most infections is 200 mg twice daily or 400 mg once daily. For uncomplicated gonorrhea, a single dose of 400 mg is recommended. For pharyngitis and tonsillitis, a 10-day course of 200 mg twice daily or 400 mg once daily is typical. For acute otitis media in children, the recommended dose is 8 mg per kg of body weight per day, divided into two doses. For children weighing more than 50 kg, the adult dose should be used. The duration of treatment varies by indication. For most infections, a 7 to 14 day course is sufficient. For uncomplicated gonorrhea, a single dose is adequate. For typhoid fever, a 10 to 14 day course is recommended. Suprax is available as 100 mg, 200 mg, and 400 mg tablets, and an oral suspension containing 100 mg per 5 mL and 200 mg per 5 mL. The tablets should be swallowed whole with a sufficient amount of liquid. The oral suspension should be shaken well before use to ensure uniform distribution of the drug. The suspension can be taken with or without food. If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next dose, the missed dose should be skipped and the regular schedule resumed. Double doses should not be taken. In patients with renal impairment, dose adjustment is required. For patients with creatinine clearance between 20 and 40 mL/min, the dose should be reduced by 25 to 50%. For patients with creatinine clearance less than 20 mL/min, the dose should be reduced by 50 to 75%. Alternative dosing recommendations for renal impairment include reducing the frequency to once daily for moderate impairment and every 48 hours for severe impairment. Patients should complete the full course of therapy as prescribed, even if symptoms improve before the medication is finished, to prevent the development of bacterial resistance. Those who buy Suprax over the counter should follow the dosage instructions carefully and complete the prescribed course.
Side effects and adverse reactions
Suprax (cefixime) is generally well tolerated, with most side effects being mild and transient. The most common adverse effects involve the gastrointestinal system. Diarrhea is the most frequently reported side effect, occurring in approximately 10 to 15% of patients. Other gastrointestinal effects include nausea, vomiting, abdominal pain, dyspepsia, and flatulence. Clostridium difficile-associated diarrhea (pseudomembranous colitis) is a potentially serious complication that can occur with any antibiotic therapy, including cefixime. Patients who develop severe, persistent diarrhea during or after treatment should be evaluated for this condition. Dermatological effects include rash, urticaria, pruritus, and, rarely, more serious conditions such as Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme. Hypersensitivity reactions ranging from mild skin rashes to severe anaphylactic reactions can occur. Patients with a history of penicillin allergy may have an increased risk of allergic reactions to cephalosporins, including cefixime. Hepatic effects include transient elevations in liver enzymes (ALT, AST, alkaline phosphatase) and, rarely, cholestatic jaundice and hepatitis. These hepatic effects are generally reversible upon discontinuation of the medication. Hematological effects include eosinophilia, leukopenia, neutropenia, thrombocytopenia, agranulocytosis, and hemolytic anemia. These effects are rare but can be serious. Renal effects include transient increases in blood urea nitrogen and serum creatinine and, rarely, acute interstitial nephritis. Central nervous system effects include headache, dizziness, vertigo, and, rarely, seizures, particularly in patients with renal impairment who receive high doses. Superinfections due to overgrowth of resistant organisms, including Candida albicans, can occur during cefixime therapy. Other reported adverse effects include arthralgia, myalgia, glossitis, stomatitis, and vaginitis. Patients should seek medical attention if they experience severe or persistent side effects. Those who buy Suprax over the counter should be aware of these potential adverse reactions and monitor their health during treatment.
Drug interactions
Suprax (cefixime) can interact with other medications, and these interactions can affect its efficacy or increase the risk of adverse effects. Unlike some other cephalosporins, cefixime does not have significant interactions with alcohol (no disulfiram-like reaction). However, alcohol consumption is generally not recommended during antibiotic therapy as it can increase the risk of side effects and may impair the immune response. Probenecid, a drug used to treat gout, can decrease the renal tubular secretion of cefixime, leading to increased plasma concentrations and a prolonged half-life. This interaction can be used therapeutically in some cases but may also increase the risk of adverse effects. The absorption of cefixime may be reduced by antacids containing aluminum or magnesium hydroxide. However, the clinical significance of this interaction is minimal, and cefixime can be taken without regard to antacids in most cases. Cefixime may enhance the anticoagulant effect of warfarin and other oral anticoagulants by reducing vitamin K production by intestinal bacteria. Patients on anticoagulant therapy should have their INR monitored when cefixime is initiated or discontinued. Cefixime may increase the nephrotoxic effects of other nephrotoxic drugs, including aminoglycosides, cyclosporine, and loop diuretics (furosemide). Concurrent use should be monitored closely. The use of cefixime with oral contraceptives may reduce the efficacy of the contraceptive, potentially leading to breakthrough bleeding or pregnancy. Although the interaction is less established than with some other antibiotics, additional barrier methods are recommended during cefixime therapy and for 7 days after completion. Cefixime may decrease the efficacy of live typhoid vaccine and other live bacterial vaccines. Vaccination should be deferred until after antibiotic therapy is completed. Cefixime should not be mixed or co-administered with aminoglycosides in the same intravenous solution due to physical incompatibility, although this is not relevant for oral cefixime. Patients should inform their healthcare provider about all medications they are taking, including prescription drugs, over-the-counter products, and herbal supplements, before starting Suprax therapy. Those who buy Suprax over the counter should be particularly careful to disclose their complete medication history to ensure safe concurrent use.
Contraindications and precautions
Suprax (cefixime) is contraindicated in patients with known hypersensitivity to cefixime, any other cephalosporin antibiotic, or any of the excipients in the formulation. Cross-sensitivity between cephalosporins and penicillins has been reported, and patients with a history of immediate-type hypersensitivity reactions to penicillin (such as anaphylaxis, angioedema, or urticaria) may be at increased risk for allergic reactions to cephalosporins. Approximately 5 to 10% of penicillin-allergic patients may also be allergic to cephalosporins. Cefixime should be used with caution in such patients, and alternative antibiotics should be considered in those with a history of severe penicillin allergy. Cefixime should be used with caution in patients with renal impairment, as the drug is primarily eliminated by the kidneys. Dose adjustment is necessary based on creatinine clearance to prevent drug accumulation and toxicity. In patients with severe renal impairment (creatinine clearance less than 20 mL/min), the dose should be reduced. Cefixime should be used with caution in patients with a history of gastrointestinal disease, particularly colitis, as it can cause Clostridium difficile-associated diarrhea. The drug should be discontinued if significant diarrhea develops during treatment. Cefixime should be used with caution in patients with a history of seizure disorders, as high doses or accumulation of cephalosporins can lower the seizure threshold. This is particularly relevant in patients with renal impairment. In patients undergoing anticoagulant therapy, the INR should be monitored closely, as cefixime can enhance the effects of anticoagulants. Cefixime should be used with caution during pregnancy and breastfeeding. Animal studies have not shown teratogenic effects, but adequate well-controlled studies in pregnant women are lacking. Cefixime should be used during pregnancy only if clearly needed. The drug is excreted in breast milk in small amounts, and caution is advised when used in nursing mothers. Cefixime is generally safe and effective for use in pediatric patients for approved indications, including otitis media. Appropriate dose adjustments based on weight should be made. In elderly patients, cefixime should be used with caution due to age-related decline in renal function, and dose adjustment based on creatinine clearance is recommended. Patients should be monitored for adverse effects, particularly gastrointestinal effects and superinfections.
Special populations
In pediatric patients, Suprax (cefixime) is approved for use in children for the treatment of acute otitis media, pharyngitis, tonsillitis, and urinary tract infections. The dosage is calculated based on body weight, typically 8 mg per kg per day divided into two doses. The oral suspension formulation is convenient for pediatric use. The safety and efficacy of cefixime in infants under 6 months of age have not been established. In elderly patients, cefixime should be used with caution due to age-related decline in renal function, which can lead to drug accumulation. Dose adjustment based on creatinine clearance is recommended in elderly patients. They may also be more susceptible to adverse effects, particularly gastrointestinal effects and superinfections. In patients with renal impairment, the dose of cefixime should be adjusted based on the degree of impairment. For patients with creatinine clearance between 20 and 40 mL/min, the dose should be reduced by 25 to 50%. For patients with creatinine clearance less than 20 mL/min, the dose should be reduced by 50 to 75%. In patients undergoing hemodialysis, cefixime is not removed, and dosing after dialysis is not required. In patients with hepatic impairment, no dose adjustment is typically required, as cefixime is primarily eliminated by the kidneys. However, caution is advised in patients with severe hepatic impairment, as the safety of cefixime in this population has not been studied. In pregnant women, cefixime should be used only if clearly needed. Animal studies have not demonstrated teratogenic effects, but adequate human studies are lacking. In nursing mothers, cefixime is excreted in breast milk in small amounts. While adverse effects in breastfed infants are unlikely, caution is recommended, and alternative antibiotics may be considered in some cases. In patients with diabetes, cefixime may cause false-positive results in urine glucose tests using copper reduction methods (Benedict’s test, Clinitest). Glucose oxidase-based tests are not affected. Patients with diabetes should be advised to use glucose oxidase-based tests for urine glucose monitoring during cefixime therapy.
Patient education and counseling
Patients prescribed Suprax should receive comprehensive counseling to ensure safe and effective therapy. They should be instructed to take the medication exactly as prescribed, at the same times each day, and to complete the full course of therapy even if they start to feel better. Skipping doses or stopping early can lead to treatment failure and antibiotic resistance. The tablets should be swallowed whole with a full glass of water. The oral suspension should be shaken well before each use, and the dose should be measured using the provided measuring device. The suspension can be taken with or without food. Patients should be informed that cefixime can be taken without regard to meals, but taking it with food may help reduce gastrointestinal side effects. If a dose is missed, it should be taken as soon as remembered. If it is almost time for the next dose, the missed dose should be skipped and the regular schedule resumed. Patients should not take double doses to make up for missed doses. Patients should be advised about common side effects, particularly diarrhea, which is the most frequently reported adverse effect. They should be counseled to contact their healthcare provider if they develop severe or persistent diarrhea, as this may indicate Clostridium difficile infection. Other symptoms that warrant medical attention include signs of allergic reaction (rash, itching, swelling, difficulty breathing), severe skin reactions, jaundice, dark urine, seizures, or bleeding. Women taking oral contraceptives should be informed that cefixime may reduce the efficacy of their birth control pills, and they should use an additional barrier method during treatment and for 7 days after completion. Patients should be advised to inform their healthcare provider about all other medications they are taking, including over-the-counter drugs and herbal supplements, to avoid potential interactions. Patients should store cefixime at room temperature, protected from light and moisture. The oral suspension should not be frozen. Unused medication should be disposed of properly after the expiration date. Patients who buy Suprax over the counter should ensure they purchase from a reputable source, such as Happy Family Store, to guarantee the quality and authenticity of the medication.
Antibiotic resistance and stewardship
The emergence of bacterial resistance to cefixime and other cephalosporins is a growing concern in clinical practice. Resistance to cefixime can occur through several mechanisms. The most significant mechanism is the production of beta-lactamases, particularly extended-spectrum beta-lactamases (ESBLs) and AmpC beta-lactamases, which can hydrolyze cefixime and render it ineffective. ESBL-producing organisms, such as Escherichia coli and Klebsiella pneumoniae, are increasingly common in both hospital and community settings and can cause infections that are difficult to treat. Another resistance mechanism involves alterations in penicillin-binding proteins (PBPs). Mutations in the genes encoding PBPs can reduce the binding affinity of cefixime, leading to resistance. This mechanism is particularly important in Streptococcus pneumoniae, where altered PBP2b and PBP2x contribute to penicillin and cephalosporin resistance. Efflux pumps can also contribute to resistance by actively transporting cefixime out of bacterial cells, reducing intracellular drug concentrations. The increasing prevalence of cephalosporin resistance, particularly in Neisseria gonorrhoeae, has become a major public health concern. Reduced susceptibility and resistance to cefixime in gonorrhea have been reported in many countries, and ceftriaxone (an injectable third-generation cephalosporin) is now recommended as the first-line treatment for gonorrhea in most guidelines. Antibiotic stewardship is essential to preserve the effectiveness of cefixime and other cephalosporins. This includes using cefixime only for confirmed or strongly suspected bacterial infections, prescribing the correct dose and duration, and avoiding unnecessary use. Susceptibility testing should guide therapy whenever possible, particularly for serious infections. The development of new antibiotics and alternative treatment strategies is critical to address the growing threat of antibiotic resistance. Patients can contribute to stewardship efforts by using cefixime responsibly and completing their prescribed course.
Comparison with other cephalosporins
Cefixime is one of several third-generation cephalosporins available for clinical use. Compared to other third-generation oral cephalosporins such as cefdinir, cefpodoxime, and ceftibuten, cefixime has distinct characteristics. Cefixime has excellent activity against gram-negative bacteria, including Haemophilus influenzae, Moraxella catarrhalis, and Neisseria gonorrhoeae, but it has relatively weak activity against Streptococcus pneumoniae compared to cefdinir and cefpodoxime. This difference in activity against pneumococci may influence the choice of antibiotic for respiratory tract infections. Cefixime has a longer half-life (3 to 4 hours) compared to cefdinir (1.5 to 2 hours) and cefpodoxime (2 to 3 hours), allowing for once or twice daily dosing. Cefpodoxime and cefdinir require dosing three times daily for some indications. In terms of absorption, cefixime has lower oral bioavailability (40 to 50%) compared to cefdinir and cefpodoxime (approximately 50 to 60%). All three drugs are stable against many beta-lactamases but can be hydrolyzed by ESBLs. Compared to injectable third-generation cephalosporins such as ceftriaxone and ceftazidime, cefixime has less potent activity against Pseudomonas aeruginosa and a narrower spectrum of activity. Injectable cephalosporins are generally reserved for more serious infections requiring hospitalization. The choice between oral cephalosporins depends on the specific infection, local resistance patterns, patient factors, and cost considerations. Patients who buy Suprax over the counter should be aware that while third-generation cephalosporins share many similarities, they are not interchangeable, and the selection should be based on the specific indication.
Storage and handling
Suprax tablets should be stored at room temperature, between 20 to 25 degrees Celsius (68 to 77 degrees Fahrenheit). The oral suspension, after reconstitution, should be stored at room temperature and used within 14 days. It should not be frozen. The suspension should be shaken well before each use to ensure uniform distribution of the drug. Tablets should be kept in their original container, tightly closed, and protected from light and moisture. The medication should be stored out of the reach and sight of children and pets. It should not be stored in the bathroom or kitchen, where humidity and temperature fluctuations may affect the stability of the medication. Any unused or expired medication should be disposed of properly through drug take-back programs or by following the disposal instructions provided with the medication. Tablets that show signs of discoloration, crumbling, or other physical changes should not be used. The suspension that has changed color or developed a strange odor should be discarded. Proper storage and handling ensure that Suprax maintains its potency and safety throughout the treatment course.
Frequently asked questions
Can i buy suprax over the counter?
Yes, at Happy Family Store, you can buy Suprax over the counter without a prescription. This trusted pharmacy offers genuine cefixime tablets and oral suspension with reliable shipping.
What infections does suprax treat?
Suprax (cefixime) treats respiratory tract infections (bronchitis, pharyngitis, tonsillitis), otitis media, urinary tract infections, uncomplicated gonorrhea, typhoid fever, and other bacterial infections caused by susceptible organisms.
How long does it take for suprax to work?
Most patients experience symptom improvement within 48 to 72 hours of starting treatment. For gonorrhea, the single-dose regimen begins working within hours. It is important to complete the full course as prescribed.
What are the common side effects of suprax?
The most common side effect is diarrhea, occurring in approximately 10 to 15% of patients. Other side effects include nausea, vomiting, abdominal pain, headache, and rash. Most side effects are mild and resolve on their own.
Can i take suprax with food?
Yes, Suprax can be taken with or without food. The absorption is not affected by food, but taking it with food may help reduce gastrointestinal side effects such as nausea and diarrhea.
Is suprax safe during pregnancy?
Suprax should be used during pregnancy only if clearly needed. Animal studies have not shown teratogenic effects, but adequate human studies are limited. Consult your healthcare provider before use if you are pregnant or planning to become pregnant.
Can i take suprax if i am allergic to penicillin?
There is a 5 to 10% risk of cross-allergenicity between penicillins and cephalosporins. Patients with a history of severe penicillin allergy should use Suprax with caution and under medical supervision. Alternative antibiotics may be recommended in some cases.
How should i take suprax?
Take Suprax exactly as prescribed. Tablets should be swallowed whole with water. The oral suspension should be shaken well before each dose. Measure the dose using the provided device for accuracy. Complete the full course of therapy.
What should i avoid while taking suprax?
Avoid alcohol consumption as it may increase the risk of side effects. Women taking oral contraceptives should use an additional barrier method during treatment. No specific food restrictions are required, but a balanced diet supportive of recovery is recommended.
Does suprax treat strep throat?
Yes, Suprax is effective against Streptococcus pyogenes, the bacterium that causes strep throat. It is a suitable alternative for patients who cannot take penicillin. A standard 10-day course is typically recommended for strep throat.